Drug shortage: Bupivacaine Hydrochloride Injection (SENSORCAINE MPF, MARCAINE SPINAL, BUPIVACAINE HYDROCHLORIDE)
FDA lists 62 presentations as Current. Availability: Unavailable (4), Limited Availability (5), Available (48). Reason: Demand increase for the drug; Other. Companies: Fresenius Kabi USA, LLC, Hospira, Inc., a Pfizer Company, Eugia US LLC, Aspiro Pharma Limited, Kindos Pharmaceuticals Co. Ltd.….
- Published by source
- 2018-02-20
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-23
Affected
- Manufacturer
- Fresenius Kabi USA, LLC
- Products
- Bupivacaine Hydrochloride Injection SENSORCAINE MPF MARCAINE SPINAL BUPIVACAINE HYDROCHLORIDE SENSORCAINE BUPIVACAINE SPINAL
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Estimated recovery: TBD
- Check wholesalers for inventory
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2018-02-20
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #879 | new | 2026-10-22 | 30c858a05cdc…876000 | b97a44c4ddd8…78330f |
| #1121 | update | 2026-10-23 | a89f5ebafecd…de62e6 | 3687bbd4f1a2…e6c5ec |
Chain head: #1250 0c9a4a81d7d8…29590d